HomeMAIA • NYSEAMERICAN
add
Maia Biotechnology Inc
$1.58
After Hours:(0.95%)-0.015
$1.57
Closed: Aug 15, 4:11:22 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer
Previous close
$1.56
Day range
$1.54 - $1.64
Year range
$1.40 - $3.74
Market cap
52.13M USD
Avg Volume
456.86K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.17M | 35.41% |
Net income | -5.35M | 39.78% |
Net profit margin | — | — |
Earnings per share | -0.17 | 58.02% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.14M | -12.39% |
Total assets | 11.05M | -8.10% |
Total liabilities | 7.17M | -19.06% |
Total equity | 3.88M | — |
Shares outstanding | 32.99M | — |
Price to book | 13.00 | — |
Return on assets | -112.74% | — |
Return on capital | -292.89% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.35M | 39.78% |
Cash from operations | -4.14M | 11.73% |
Cash from investing | — | — |
Cash from financing | 3.41M | -57.33% |
Net change in cash | -718.77K | -121.73% |
Free cash flow | -2.34M | 30.70% |
About
MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells. Wikipedia
Founded
2018
Headquarters
Website
Employees
13
